67 related articles for article (PubMed ID: 9101317)
1. Cell transformation assays as predictors of human carcinogenicity.
Combes R; Balls M; Curren R; Fischbach M; Fusenig N; Kirkland D; Lasne C; Landolph J; LeBoeuf R; Marquardt H; McCormick J; Müller L; Rivedal E; Sabbioni E; Tanaka N; Vasseur P; Yamasaki H
Altern Lab Anim; 1999; 27(5):745-67. PubMed ID: 25490287
[No Abstract] [Full Text] [Related]
2. Non-neoplastic and neoplastic pleural endpoints following fiber exposure.
Broaddus VC; Everitt JI; Black B; Kane AB
J Toxicol Environ Health B Crit Rev; 2011; 14(1-4):153-78. PubMed ID: 21534088
[TBL] [Abstract][Full Text] [Related]
3. Biopersistence and potential adverse health impacts of fibrous nanomaterials: what have we learned from asbestos?
Sanchez VC; Pietruska JR; Miselis NR; Hurt RH; Kane AB
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(5):511-29. PubMed ID: 20049814
[TBL] [Abstract][Full Text] [Related]
4. Mesothelioma: Do asbestos and carbon nanotubes pose the same health risk?
Jaurand MC; Renier A; Daubriac J
Part Fibre Toxicol; 2009 Jun; 6():16. PubMed ID: 19523217
[TBL] [Abstract][Full Text] [Related]
5. New insight into intrachromosomal deletions induced by chrysotile in the gpt delta transgenic mutation assay.
Xu A; Smilenov LB; He P; Masumura K; Nohmi T; Yu Z; Hei TK
Environ Health Perspect; 2007 Jan; 115(1):87-92. PubMed ID: 17366825
[TBL] [Abstract][Full Text] [Related]
6. Inhaled crocidolite mutagenicity in lung DNA.
Rihn B; Coulais C; Kauffer E; Bottin MC; Martin P; Yvon F; Vigneron JC; Binet S; Monhoven N; Steiblen G; Keith G
Environ Health Perspect; 2000 Apr; 108(4):341-6. PubMed ID: 10753093
[TBL] [Abstract][Full Text] [Related]
7. Biological effects of naturally occurring and man-made fibres: in vitro cytotoxicity and mutagenesis in mammalian cells.
Okayasu R; Wu L; Hei TK
Br J Cancer; 1999 Mar; 79(9-10):1319-24. PubMed ID: 10188871
[TBL] [Abstract][Full Text] [Related]
8. Use of in-vitro genotoxicity and cell transformation assays to evaluate the potential carcinogenicity of fibres.
Jaurand MC
IARC Sci Publ; 1996; (140):55-72. PubMed ID: 9101317
[No Abstract] [Full Text] [Related]
9. Application of toxicogenomics to study mechanisms of genotoxicity and carcinogenicity.
Ellinger-Ziegelbauer H; Aubrecht J; Kleinjans JC; Ahr HJ
Toxicol Lett; 2009 Apr; 186(1):36-44. PubMed ID: 18822359
[TBL] [Abstract][Full Text] [Related]
10. Chemically induced cell proliferation as a criterion in selecting doses for long-term bioassays.
Swenberg JA; Maronpot RR
Prog Clin Biol Res; 1991; 369():245-51. PubMed ID: 1946523
[No Abstract] [Full Text] [Related]
11. Chemical-induced transformation in BALB/c-3T3 cells: relationship between in vitro transformation and cytotoxicity, carcinogenesis, and genotoxicity.
Matthews EJ
Prog Clin Biol Res; 1990; 340D():229-38. PubMed ID: 2371296
[No Abstract] [Full Text] [Related]
12. Mechanisms of mineral fibre carcinogenesis.
Kane AB
IARC Sci Publ; 1996; (140):11-34. PubMed ID: 9101315
[No Abstract] [Full Text] [Related]
13. Evaluation of high-throughput genotoxicity assays used in profiling the US EPA ToxCast chemicals.
Knight AW; Little S; Houck K; Dix D; Judson R; Richard A; McCarroll N; Akerman G; Yang C; Birrell L; Walmsley RM
Regul Toxicol Pharmacol; 2009 Nov; 55(2):188-99. PubMed ID: 19591892
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
